IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v41y2012i1p1-12.html
   My bibliography  Save this item

The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Yi Zhang & Mingting Kou & Kaihua Chen & Jiancheng Guan & Yuchen Li, 2016. "Modelling the Basic Research Competitiveness Index (BR-CI) with an application to the biomass energy field," Scientometrics, Springer;Akadémiai Kiadó, vol. 108(3), pages 1221-1241, September.
  2. Yin, Zhifeng & Liang, Zheng & Zhi, Qiang, 2018. "Does the concentration of scientific research funding in institutions promote knowledge output?," Journal of Informetrics, Elsevier, vol. 12(4), pages 1146-1159.
  3. Caloffi, Annalisa & Colovic, Ana & Rizzoli, Valentina & Rossi, Federica, 2023. "Innovation intermediaries' types and functions: A computational analysis of the literature," Technological Forecasting and Social Change, Elsevier, vol. 189(C).
  4. Ryan, James Christopher & Berbegal-Mirabent, Jasmina, 2016. "Motivational recipes and research performance: A fuzzy set analysis of the motivational profile of high performing research scientists," Journal of Business Research, Elsevier, vol. 69(11), pages 5299-5304.
  5. Kolympiris, Christos & Kalaitzandonakes, Nicholas & Miller, Douglas, 2014. "Public funds and local biotechnology firm creation," Research Policy, Elsevier, vol. 43(1), pages 121-137.
  6. Paolo Castelnovo & Martina Dal Molin, 2021. "The learning mechanisms through public procurement for innovation: The case of government‐funded basic research organizations," Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 92(3), pages 411-446, September.
  7. Heyen, Nils B. & Zenker, Andrea & Aichinger, Heike & Bratan, Tanja & Kaufmann, Tanja & Schnabl, Esther, 2024. "Innovation without growth? Exploring the (in)dependency of innovation on economic growth," Discussion Papers "Innovation Systems and Policy Analysis" 83, Fraunhofer Institute for Systems and Innovation Research (ISI).
  8. Beck, Mathias & Junge, Martin & Kaiser, Ulrich, 2017. "Public Funding and Corporate Innovation," IZA Discussion Papers 11196, Institute of Labor Economics (IZA).
  9. Lutz Bornmann, 2013. "What is societal impact of research and how can it be assessed? a literature survey," Journal of the Association for Information Science & Technology, Association for Information Science & Technology, vol. 64(2), pages 217-233, February.
  10. Andrea Bastianin & Paolo Castelnovo & Massimo Florio & Anna Giunta, 2019. "Technological Learning and Innovation Gestation Lags at the Frontier of Science: from CERN Procurement to Patent," Papers 1905.09552, arXiv.org.
  11. Kang, Yankun & Liu, Ruiming, 2021. "Does the merger of universities promote their scientific research performance? Evidence from China," Research Policy, Elsevier, vol. 50(1).
  12. Hans Gersbach & Ulrich Schetter & Maik T Schneider, 2019. "Taxation, Innovation and Entrepreneurship," The Economic Journal, Royal Economic Society, vol. 129(620), pages 1731-1781.
  13. Diekhoff, Josefine & Krieger, Bastian & Licht, Georg & Rammer, Christian, 2019. "Stand der Messung von Interaktionen zwischen Wissenschaft und Wirtschaft im internationalen Vergleich," ZEW Expertises, ZEW - Leibniz Centre for European Economic Research, number 248650.
  14. Gersbach, Hans & Schneider, Maik & Schetter, Ulrich, 2015. "How Much Science? The 5 Ws (and 1 H) of Investing in Basic Research," CEPR Discussion Papers 10482, C.E.P.R. Discussion Papers.
  15. Robbiano, Simone, 2022. "The innovative impact of public research institutes: Evidence from Italy," Research Policy, Elsevier, vol. 51(10).
  16. Agarwal, Ruchir & Gaule, Patrick, 2022. "What drives innovation? Lessons from COVID-19 R&D," Journal of Health Economics, Elsevier, vol. 82(C).
  17. Chen, Zhuo & Yang, Zhenbing & Yang, Lili, 2020. "How to optimize the allocation of research resources? An empirical study based on output and substitution elasticities of universities in Chinese provincial level," Socio-Economic Planning Sciences, Elsevier, vol. 69(C).
  18. Guijie Zhang & Guang Yu & Yuqiang Feng & Luning Liu & Zhenhua Yang, 2017. "Improving the publication delay model to characterize the patent granting process," Scientometrics, Springer;Akadémiai Kiadó, vol. 111(2), pages 621-637, May.
  19. Zhuo Chen & Zhenbing Yang & Lili Yang, 2024. "Analyzing the Knowledge Transfer Performance of China’s Universities: a Heterogeneous Stochastic Frontier Approach," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 15(1), pages 3975-4003, March.
  20. Bastian Rake, 2017. "Determinants of pharmaceutical innovation: the role of technological opportunities revisited," Journal of Evolutionary Economics, Springer, vol. 27(4), pages 691-727, September.
  21. Laurent Bach & Sandrine Wolff, 2022. "The BETA-EvaRIO impact evaluation method: towards a bridging approach?," The Journal of Technology Transfer, Springer, vol. 47(3), pages 651-672, June.
  22. Gersbach, Hans & Schetter, Ulrich & Schmassmann, Samuel, 2023. "From local to global: A theory of public basic research in a globalized world," European Economic Review, Elsevier, vol. 160(C).
  23. Guijie Zhang & Yuqiang Feng & Guang Yu & Luning Liu & Yanqiqi Hao, 2017. "Analyzing the time delay between scientific research and technology patents based on the citation distribution model," Scientometrics, Springer;Akadémiai Kiadó, vol. 111(3), pages 1287-1306, June.
  24. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
  25. Agustí Segarra‐Blasco & Mercedes Teruel & Sebastiano Cattaruzzo, 2024. "The international trade in human vaccines before COVID‐19," The World Economy, Wiley Blackwell, vol. 47(5), pages 1978-2008, May.
  26. Paige Clayton & Maryann Feldman & Benjamin Montmartin, 2019. "Funding Emerging Ecosystems," GREDEG Working Papers 2019-25, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France.
  27. Laurent Bach & Sandrine Wolff, 2017. "The BETA-EvaRIO impact evaluation method: towards a bridging approach?," Post-Print hal-02167827, HAL.
  28. René Belderbos & Nazareno Braito & Jian Wang, 2024. "Heterogeneous university research and firm R&D location decisions: research orientation, academic quality, and investment type," The Journal of Technology Transfer, Springer, vol. 49(5), pages 1959-1989, October.
  29. Ciro D. Esposito & Balazs Szatmari & Jonathan M. C. Sitruk & Nachoem M. Wijnberg, 2024. "Getting off to a good start: emerging academic fields and early-stage equity financing," Small Business Economics, Springer, vol. 62(4), pages 1591-1613, April.
  30. Kalcheva, Ivalina & McLemore, Ping & Pant, Shagun, 2018. "Innovation: The interplay between demand-side shock and supply-side environment," Research Policy, Elsevier, vol. 47(2), pages 440-461.
  31. René BELDERBOS & IKEUCHI Kenta & FUKAO Kyoji & KIM Young Gak & KWON Hyeog Ug, 2022. "What Do R&D Spillovers from Universities and Firms Contribute to Productivity? Plant level productivity and technological and geographic proximity in Japan," Discussion papers 22106, Research Institute of Economy, Trade and Industry (RIETI).
  32. Hans Gersbach & Ulrich Schetter & Maik T. Schneider, 2021. "Macroeconomic Rationales For Public Investments In Science," Economic Inquiry, Western Economic Association International, vol. 59(2), pages 575-599, April.
  33. Laurent R Bergé & Thorsten Doherr & Katrin Hussinger, 2023. "How patent rights affect university science," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 32(3), pages 673-699.
  34. Keye Wu & Ziyue Xie & Jia Tina Du, 2024. "Does science disrupt technology? Examining science intensity, novelty, and recency through patent-paper citations in the pharmaceutical field," Scientometrics, Springer;Akadémiai Kiadó, vol. 129(9), pages 5469-5491, September.
  35. Manuel Hermosilla & Jorge Lemus, 2018. "Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 21-52, National Bureau of Economic Research, Inc.
  36. Qinghua Xia & Qinwei Cao & Manqing Tan, 2020. "Basic research intensity and diversified performance: the moderating role of government support intensity," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(1), pages 577-605, October.
  37. Ke, Qing, 2020. "The citation disadvantage of clinical research," Journal of Informetrics, Elsevier, vol. 14(1).
  38. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.
  39. Chen, Yin-E & Li, Chunyan & Chang, Chun-Ping & Zheng, Mingbo, 2021. "Identifying the influence of natural disasters on technological innovation," Economic Analysis and Policy, Elsevier, vol. 70(C), pages 22-36.
  40. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
  41. Prettner, Klaus & Werner, Katharina, 2016. "Why it pays off to pay us well: The impact of basic research on economic growth and welfare," Research Policy, Elsevier, vol. 45(5), pages 1075-1090.
  42. Bhaven Sampat, 2022. "Second World War and the direction of medical innovation," WIPO Economic Research Working Papers 70, World Intellectual Property Organization - Economics and Statistics Division.
  43. Shi‐Xiao Wang & Wen‐Min Lu & Shiu‐Wan Hung, 2020. "Industrial upgrading efficiency and free markets in emerging economies: A two‐stage meta‐frontier approach," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 41(6), pages 1084-1095, September.
  44. Wang, Fang, 2024. "Does the recombination of distant scientific knowledge generate valuable inventions? An analysis of pharmaceutical patents," Technovation, Elsevier, vol. 130(C).
  45. Margaret Dalziel, 2018. "Why are there (almost) no randomised controlled trial-based evaluations of business support programmes?," Palgrave Communications, Palgrave Macmillan, vol. 4(1), pages 1-9, December.
  46. Dirk Czarnitzki & Christian Rammer & Andrew Toole, 2014. "University spin-offs and the “performance premium”," Small Business Economics, Springer, vol. 43(2), pages 309-326, August.
  47. Mark Pauly & Kyle Myers, 2016. "A Ricardian-Demand Explanation for Changing Pharmaceutical R&D Productivity," NBER Working Papers 22720, National Bureau of Economic Research, Inc.
  48. David Popp, 2015. "Using Scientific Publications to Evaluate Government R&D Spending: The Case of Energy," CESifo Working Paper Series 5442, CESifo.
  49. Pintu Parui & Klaus Prettner, 2024. "Public provision of healthcare and basic science: What are the effects on economic growth and welfare?," Department of Economics Working Papers wuwp365, Vienna University of Economics and Business, Department of Economics.
  50. Robbiano, Simone, 2021. "The innovative impact of public research institutes: evidence from Italy," MPRA Paper 106386, University Library of Munich, Germany.
  51. David Popp, 2015. "Using Scientific Publications to Evaluate Government R&D Spending: The Case of Energy," NBER Working Papers 21415, National Bureau of Economic Research, Inc.
  52. Beth Woods & James Lomas & Mark Sculpher & Helen Weatherly & Karl Claxton, 2024. "Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 804-819, April.
  53. Park, Hyunwoo & Lee, Jeongsik (Jay) & Kim, Byung-Cheol, 2015. "Project selection in NIH: A natural experiment from ARRA," Research Policy, Elsevier, vol. 44(6), pages 1145-1159.
  54. Parui, Pintu, 2023. "Health, basic research, human capital accumulation, and R&D-based economic growth," MPRA Paper 118769, University Library of Munich, Germany.
  55. Felipa de Mello-Sampayo & Sofia de Sousa-Vale & Francisco Camoes, 2015. "Substitutability Between Drugs, Innovation, and Fiscal Policy in the Pharmaceutical Industry," Annals of Economics and Finance, Society for AEF, vol. 16(2), pages 273-289, November.
  56. Andrea Bastianin & Paolo Castelnovo & Massimo Florio & Anna Giunta, 2022. "Big science and innovation: gestation lag from procurement to patents for CERN suppliers," The Journal of Technology Transfer, Springer, vol. 47(2), pages 531-555, April.
  57. Christoph Roesler & Tom Broekel, 2017. "The role of universities in a network of subsidized R&D collaboration: The case of the biotechnology-industry in Germany," Review of Regional Research: Jahrbuch für Regionalwissenschaft, Springer;Gesellschaft für Regionalforschung (GfR), vol. 37(2), pages 135-160, October.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.